Compounds > tristearin
Page last updated: 2024-08-21

tristearin and Colorectal Neoplasms

tristearin has been researched along with Colorectal Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bailey, R; Buanz, A; Gershkovich, P; Lee, JB; Pasparakis, G; Sanchez-Vazquez, B; Strimaite, M; Williams, GR1
Jain, SK; Rajpoot, K1

Other Studies

2 other study(ies) available for tristearin and Colorectal Neoplasms

ArticleYear
Solid lipid nanoparticles self-assembled from spray dried microparticles.
    International journal of pharmaceutics, 2019, Dec-15, Volume: 572

    Topics: Administration, Oral; Aerosols; Caco-2 Cells; Cell Survival; Colorectal Neoplasms; Delayed-Action Preparations; Drug Compounding; Drug Liberation; Drug Stability; Fluorouracil; Humans; Hydrophobic and Hydrophilic Interactions; Indomethacin; Nanoparticles; Povidone; Solubility; Triglycerides

2019
Colorectal cancer-targeted delivery of oxaliplatin via folic acid-grafted solid lipid nanoparticles: preparation, optimization, and in vitro evaluation.
    Artificial cells, nanomedicine, and biotechnology, 2018, Volume: 46, Issue:6

    Topics: Cell Survival; Colorectal Neoplasms; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Drug Liberation; Folic Acid; HT29 Cells; Humans; Nanoparticles; Organoplatinum Compounds; Oxaliplatin; Particle Size; Surface Properties; Triglycerides

2018